Home › Alpha-1 Antitrypsin Deficiency › Minnesota › Rochester
Alpha-1 Antitrypsin Deficiency clinical trials in Rochester, MN
4 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
RecruitingPhase 1/2
- Clinical Study Center, Rochester
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
- GC2501 Study Site 108, Rochester
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
RecruitingPhase 3
- Mayo Clinic - PPDS, Rochester
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
RecruitingPhase 3
- Mayo Clinic PPDS, Rochester
About Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency is an inherited condition that raises your risk for lung and liver disease. Learn about the symptoms and treatment.
More about Alpha-1 Antitrypsin Deficiency on MedlinePlus
Alpha-1 Antitrypsin Deficiency trials in other cities
- Gainesville, FL6 studies
- Charleston, SC6 studies
- Birmingham, AL5 studies
- Boston, MA4 studies
- New York City, NY4 studies
- Miami, FL3 studies
- Phoenix, AZ3 studies
- Cleveland, OH3 studies
- Los Angeles, CA3 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)30 studies
- Metastatic Cancer30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Pancreatic Cancer23 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.